Official UK procurement notice
REMDESIVIR · UK public procurement notice
Authority: Belfast Health & Social Care Trust (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£700,000published contract · exc. VAT
Awarded 7 Feb 2024no call for competition
Awarded to Gilead Sciences Ltd
What is being bought
Published requirement descriptionProcurement of REMDESIVIR
CPV: Medical equipments, pharmaceuticals and personal care products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 15 Feb 2024, 10:36 GMT
- Last source update
- 15 Feb 2024, 10:36 GMT
- Authority reference
DACPM2023-104- FTS notice number
2024/S 000-005043- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-043a53Find a Tender
- Why no open competition
- Additional deliveries by the original supplier ordered under the strict conditions stated in the directive
- Published justification
These essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £700,0001 contract exc. VAT
Bids received 1
Contracts signed 1latest 7 Feb 2024
| Awarded to | Value | Date | Status |
|---|---|---|---|
| Gilead Sciences Ltd | £700,000 † | — | Awarded |
Contracts
REMDESIVIR · Gilead Sciences Ltd
- Signed
- 7 Feb 2024
- Value
- £700,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Gilead Sciences LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.